# Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma

> **NCT01247337** · PHASE2 · COMPLETED · sponsor: **Dorte Nielsen** · enrollment: 56 (actual)

## Conditions studied

- Cholangiocarcinoma

## Interventions

- **DRUG:** Oxaliplatin, capecitabine, gemcitabine, cetuximab
- **DRUG:** Oxaliplatin, capecitabine, gemcitabine cetuximab

## Key facts

- **NCT ID:** NCT01247337
- **Lead sponsor:** Dorte Nielsen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02-02
- **Primary completion:** 2016-02-18
- **Final completion:** 2016-02-18
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2020-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01247337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01247337, "Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01247337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*